{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:32:43Z","timestamp":1794058363783,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01969-y","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:34:39Z","timestamp":1783996479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-omics machine learning-driven investigation of super-enhancers signatures and prognostic biomarkers in lung adenocarcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Kai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"1969_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41467-024-55378-5","volume":"16","author":"B Alsaed","year":"2025","unstructured":"Alsaed B, Lin L, Son J, Li J, Smolander J, Lopez T, Eser P\u00d6, Ogino A, Ambrogio C et al (2025) Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment. Nat Commun 16:28. https:\/\/doi.org\/10.1038\/s41467-024-55378-5","journal-title":"Nat Commun"},{"key":"1969_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-023-10103-4","volume":"42","author":"M Bacabac","year":"2023","unstructured":"Bacabac M, Xu W (2023) Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. Cancer Metastasis Rev 42:471\u2013480. https:\/\/doi.org\/10.1007\/s10555-023-10103-4","journal-title":"Cancer Metastasis Rev"},{"key":"1969_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","volume":"389","author":"AV Balar","year":"2016","unstructured":"Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J et al (2016) Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet 389:67\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(16)32455-2","journal-title":"Lancet"},{"key":"1969_CR4","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.jtho.2025.06.012","volume":"20","author":"A Banerjee","year":"2025","unstructured":"Banerjee A, Vathiotis I, Halder D, Sen U, Wang X, Shields MD, Veluswamy RR, Syrigos K, Hirsch FR et al (2025) Molecular landscape and therapeutic strategies of lung cancer lineage plasticity. J Thorac Oncol 20:1582\u20131593. https:\/\/doi.org\/10.1016\/j.jtho.2025.06.012","journal-title":"J Thorac Oncol"},{"key":"1969_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108\u2013112. https:\/\/doi.org\/10.1038\/nature08460","journal-title":"Nature"},{"key":"1969_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","volume":"154","author":"A Basu","year":"2013","unstructured":"Basu A, Bodycombe NE, Cheah JH, Price EV, Liu K, Schaefer GI, Ebright RY, Stewart ML, Ito D et al (2013) An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell 154:1151\u20131161. https:\/\/doi.org\/10.1016\/j.cell.2013.08.003","journal-title":"Cell"},{"key":"1969_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40425-018-0382-2","volume":"6","author":"JR Brahmer","year":"2018","unstructured":"Brahmer JR, Govindan R, Anders RA, Antonia SJ, Sagorsky S, Davies MJ, Dubinett SM, Ferris A, Gandhi L et al (2018) The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J Immunother Cancer 6:75. https:\/\/doi.org\/10.1186\/s40425-018-0382-2","journal-title":"J Immunother Cancer"},{"key":"1969_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41698-023-00408-6","volume":"7","author":"T-G Chang","year":"2023","unstructured":"Chang T-G, Cao Y, Shulman ED, Ben-David U, Sch\u00e4ffer AA, Ruppin E (2023) Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations. NPJ Precis Oncol 7:54. https:\/\/doi.org\/10.1038\/s41698-023-00408-6","journal-title":"NPJ Precis Oncol"},{"key":"1969_CR9","doi-asserted-by":"publisher","first-page":"1533048","DOI":"10.3389\/fonc.2025.1533048","volume":"15","author":"L Chen","year":"2025","unstructured":"Chen L, Liu J, Lu J, Hu X, An E, Zhao Y (2025) First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis. Front Oncol 15:1533048. https:\/\/doi.org\/10.3389\/fonc.2025.1533048","journal-title":"Front Oncol"},{"key":"1969_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, Humeidi R, Peck D, Wu X et al (2020) Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer 1:235\u2013248. https:\/\/doi.org\/10.1038\/s43018-019-0018-6","journal-title":"Nat Cancer"},{"issue":"2","key":"1969_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ymeth.2003.11.023","volume":"33","author":"B Dalby","year":"2004","unstructured":"Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, Ciccarone VC (2004) Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 33(2):95\u2013103","journal-title":"Methods"},{"key":"1969_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2024.102067","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S (2024a) Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosis. Gene Rep. https:\/\/doi.org\/10.1016\/j.genrep.2024.102067","journal-title":"Gene Rep"},{"key":"1969_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/omi.2024.0175","volume":"28","author":"S Dasgupta","year":"2024","unstructured":"Dasgupta S (2024b) Next-generation cancer phenomics: a transformative approach to unraveling lung cancer complexity and advancing precision medicine. OMICS 28:585\u2013595. https:\/\/doi.org\/10.1089\/omi.2024.0175","journal-title":"OMICS"},{"issue":"1","key":"1969_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/omi.2024.0179","volume":"29","author":"S Dasgupta","year":"2025","unstructured":"Dasgupta S (2025) Multiplexed Molecular Endophenotypes Help Identify Hub Genes in Non-Small Cell Lung Cancer: Unlocking Next-Generation Cancer Phenomics. Omics 29(1):8\u201317. https:\/\/doi.org\/10.1089\/omi.2024.0179","journal-title":"Omics"},{"key":"1969_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","volume":"9","author":"SD Der","year":"2014","unstructured":"Der SD, Sykes J, Pintilie M, Zhu C-Q, Strumpf D, Liu N, Jurisica I, Shepherd FA, Tsao M-S (2014) Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J Thorac Oncol 9:59\u201364. https:\/\/doi.org\/10.1097\/JTO.0000000000000042","journal-title":"J Thorac Oncol"},{"key":"1969_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/ki.2008.294","volume":"74","author":"PC van Dijk","year":"2008","unstructured":"van Dijk PC, Jager KJ, Zwinderman AH, Zoccali C, Dekker FW (2008) The analysis of survival data in nephrology: basic concepts and methods of Cox regression. Kidney Int 74:705\u2013709. https:\/\/doi.org\/10.1038\/ki.2008.294","journal-title":"Kidney Int"},{"key":"1969_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009224","volume":"17","author":"R Duan","year":"2021","unstructured":"Duan R, Gao L, Gao Y, Hu Y, Xu H, Huang M, Song K, Wang H, Dong Y et al (2021) Evaluation and comparison of multi-omics data integration methods for cancer subtyping. PLoS Comput Biol 17:e1009224. https:\/\/doi.org\/10.1371\/journal.pcbi.1009224","journal-title":"PLoS Comput Biol"},{"key":"1969_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3322\/caac.21652","volume":"71","author":"LW Elmore","year":"2020","unstructured":"Elmore LW, Greer SF, Daniels EC, Saxe CC, Melner MH, Krawiec GM, Cance WG, Phelps WC (2020) Blueprint for cancer research: critical gaps and opportunities. CA Cancer J Clin 71:107\u2013139. https:\/\/doi.org\/10.3322\/caac.21652","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1969_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/bib\/bbae243","volume":"25","author":"C Fan","year":"2024","unstructured":"Fan C, Chen F, Chen Y, Huang L, Wang M, Liu Y, Wang Y, Guo H, Zheng N et al (2024) irGSEA: the integration of single-cell rank-based gene set enrichment analysis. Brief Bioinform 25(4):243. https:\/\/doi.org\/10.1093\/bib\/bbae243","journal-title":"Brief Bioinform"},{"key":"1969_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41419-023-06047-w","volume":"14","author":"Y Feng","year":"2023","unstructured":"Feng Y, Zhang T, Zhang Z, Liang Y, Wang H, Chen Y, Yu X, Song X, Mao Q et al (2023) The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. Cell Death Dis 14:551. https:\/\/doi.org\/10.1038\/s41419-023-06047-w","journal-title":"Cell Death Dis"},{"key":"1969_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, Kang B, Liu Z, Jin L et al (2018) Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med 24:978\u2013985. https:\/\/doi.org\/10.1038\/s41591-018-0045-3","journal-title":"Nat Med"},{"key":"1969_CR22","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1038\/s41598-019-48992-7","volume":"9","author":"J Guo","year":"2019","unstructured":"Guo J, Li X, Zhang W, Chen Y, Zhu S, Chen L, Xu R, Lv Y, Wu D et al (2019) HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer. Sci Rep 9:12628. https:\/\/doi.org\/10.1038\/s41598-019-48992-7","journal-title":"Sci Rep"},{"key":"1969_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14533","volume":"75","author":"R Gupta","year":"2021","unstructured":"Gupta R, Smalley M, Anusim N, Jindal V, Singh Rahi M, Gupta S, Gupta S, Jaiyesimi I (2021) Paradigm shift in the management of metastatic nonsmall cell lung cancer. Int J Clin Pract 75:e14533. https:\/\/doi.org\/10.1111\/ijcp.14533","journal-title":"Int J Clin Pract"},{"key":"1969_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18:533\u2013548. https:\/\/doi.org\/10.1038\/s41568-018-0038-z","journal-title":"Nat Rev Cancer"},{"key":"1969_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform 14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7","journal-title":"BMC Bioinform"},{"key":"1969_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andr\u00e9 V, Sigova AA, Hoke HA, Young RA (2013) Super-enhancers in the control of cell identity and disease. Cell 155:934\u2013947. https:\/\/doi.org\/10.1016\/j.cell.2013.09.053","journal-title":"Cell"},{"key":"1969_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001195","volume":"2","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Brunet J-P, Tamayo P, Golub TR, Mesirov JP (2007) Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE 2:e1195","journal-title":"PLoS ONE"},{"key":"1969_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217272","volume":"604","author":"S Huang","year":"2024","unstructured":"Huang S, Chung JY-F, Li C, Wu Y, Qiao G, To K-F, Tang PM-K (2024) Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma. Cancer Lett 604:217272. https:\/\/doi.org\/10.1016\/j.canlet.2024.217272","journal-title":"Cancer Lett"},{"key":"1969_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cell.2018.03.042","volume":"173","author":"C Hutter","year":"2018","unstructured":"Hutter C, Zenklusen JC (2018) The Cancer Genome Atlas: creating lasting value beyond its data. Cell 173:283\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2018.03.042","journal-title":"Cell"},{"key":"1969_CR30","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"key":"1969_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, Myung P, Plikus MV, Nie Q (2021) Inference and analysis of cell-cell communication using Cell Chat. Nat Commun 12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9","journal-title":"Nat Commun"},{"key":"1969_CR32","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","volume":"10","author":"H Jung","year":"2019","unstructured":"Jung H, Kim HS, Kim JY, Sun J-M, Ahn JS, Ahn M-J, Park K, Esteller M, Lee S-H et al (2019) DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load. Nat Commun 10:4278. https:\/\/doi.org\/10.1038\/s41467-019-12159-9","journal-title":"Nat Commun"},{"issue":"22","key":"1969_CR33","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.3390\/jcm14228021","volume":"14","author":"S Khan","year":"2025","unstructured":"Khan S, Upadhyay S, Kauser S, Hasan GM, Lu W, Waters M, Hassan MI, Sohal SS (2025) Redefining the Diagnostic and Therapeutic Landscape of Non-Small Cell Lung Cancer in the Era of Precision Medicine. J Clin Med 14(22):8021. https:\/\/doi.org\/10.3390\/jcm14228021","journal-title":"J Clin Med"},{"key":"1969_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.102022","volume":"24","author":"DP Klebl","year":"2020","unstructured":"Klebl DP, Feasey MC, Hesketh EL, Ranson NA, Wurdak H, Sobott F, Bon RS, Muench SP (2020) Cryo-EM structure of human mitochondrial HSPD1. iScience 24:102022. https:\/\/doi.org\/10.1016\/j.isci.2020.102022","journal-title":"iScience"},{"key":"1969_CR35","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P-R et al (2019) Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16:1289\u20131296. https:\/\/doi.org\/10.1038\/s41592-019-0619-0","journal-title":"Nat Methods"},{"key":"1969_CR36","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41467-017-01460-0","volume":"8","author":"M Lauss","year":"2017","unstructured":"Lauss M, Donia M, Harbst K, Andersen R, Mitra S, Rosengren F, Salim M, Vallon-Christersson J, T\u00f6rngren T et al (2017) Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat Commun 8:1738. https:\/\/doi.org\/10.1038\/s41467-017-01460-0","journal-title":"Nat Commun"},{"key":"1969_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A et al (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2009.10.027","journal-title":"Cell"},{"issue":"13","key":"1969_CR38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3390\/cancers16132350","volume":"16","author":"T Li","year":"2024","unstructured":"Li T, Ma W, Al-Obeidi E (2024) Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer. Cancers 16(13):2350. https:\/\/doi.org\/10.3390\/cancers16132350","journal-title":"Cancers"},{"key":"1969_CR39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153:320\u2013334. https:\/\/doi.org\/10.1016\/j.cell.2013.03.036","journal-title":"Cell"},{"key":"1969_CR40","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu X, Meng J, Zhou Y, Jiang L, Yan F (2021) MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics 36:5539\u20135541. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018","journal-title":"Bioinformatics"},{"key":"1969_CR41","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28:1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118","journal-title":"Genome Res"},{"key":"1969_CR42","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1002\/imt2.147","volume":"2","author":"J Meng","year":"2023","unstructured":"Meng J, Jiang A, Lu X, Gu D, Ge Q, Bai S, Zhou Y, Zhou J, Hao Z et al (2023) Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. Imeta 2:e147. https:\/\/doi.org\/10.1002\/imt2.147","journal-title":"Imeta"},{"key":"1969_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12:41","journal-title":"Genome Biol"},{"key":"1969_CR44","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.trecan.2020.04.009","volume":"6","author":"J O'Malley","year":"2020","unstructured":"O\u2019Malley J, Kumar R, Inigo J, Yadava N, Chandra D (2020) Mitochondrial Stress Response and Cancer. Trends in Cancer 6:688\u2013701. https:\/\/doi.org\/10.1016\/j.trecan.2020.04.009","journal-title":"Trends in Cancer"},{"key":"1969_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2011","unstructured":"Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T et al (2011) Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res 72:100\u2013111. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1403","journal-title":"Cancer Res"},{"key":"1969_CR46","doi-asserted-by":"publisher","first-page":"100888","DOI":"10.1016\/j.drup.2022.100888","volume":"65","author":"B Parma","year":"2022","unstructured":"Parma B, Wurdak H, Ceppi P (2022) Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins. Drug Resistance Updates 65:100888. https:\/\/doi.org\/10.1016\/j.drup.2022.100888","journal-title":"Drug Resistance Updates"},{"issue":"7","key":"1969_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.molcel.2025.03.001","volume":"85","author":"JL Pulice","year":"2025","unstructured":"Pulice JL, Meyerson M (2025) Amplified dosage of the NKX2\u20131 lineage transcription factor controls its oncogenic role in lung adenocarcinoma. Molecular Cell 85(7):1311\u201329. https:\/\/doi.org\/10.1016\/j.molcel.2025.03.001","journal-title":"Molecular Cell"},{"key":"1969_CR48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41467-023-36062-6","volume":"14","author":"B Ru","year":"2023","unstructured":"Ru B, Huang J, Zhang Y, Aldape K, Jiang P (2023) Estimation of cell lineages in tumors from spatial transcriptomics data. Nat Commun 14:568. https:\/\/doi.org\/10.1038\/s41467-023-36062-6","journal-title":"Nat Commun"},{"key":"1969_CR49","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/onc.2015.375","volume":"35","author":"MB Schabath","year":"2015","unstructured":"Schabath MB, Welsh EA, Fulp WJ, Chen L, Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE et al (2015) Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. Oncogene 35:3209\u20133216. https:\/\/doi.org\/10.1038\/onc.2015.375","journal-title":"Oncogene"},{"key":"1969_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, Sieber A, Uhlitz F, Sauer S, Garnett MJ, Bl\u00fcthgen N, Saez-Rodriguez J (2018) Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun 9:20. https:\/\/doi.org\/10.1038\/s41467-017-02391-6","journal-title":"Nat Commun"},{"key":"1969_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.soc.2019.08.002","volume":"29","author":"DR Shah","year":"2019","unstructured":"Shah DR, Masters GA (2019) Precision medicine in lung cancer treatment. Surg Oncol Clin N Am 29:15\u201321. https:\/\/doi.org\/10.1016\/j.soc.2019.08.002","journal-title":"Surg Oncol Clin N Am"},{"key":"1969_CR52","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.1790","volume":"14","author":"K Shedden","year":"2008","unstructured":"Shedden K, Taylor JMG, Enkemann SA, Tsao M-S, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ et al (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14:822\u2013827. https:\/\/doi.org\/10.1038\/nm.1790","journal-title":"Nat Med"},{"key":"1969_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218158","volume":"638","author":"A Shen","year":"2025","unstructured":"Shen A, Zheng S, Tang X, Yao Y, Yin E, Sun N, He J (2025) Integrated multi-omics analyses identified the H3K18la-based spatiotemporal characteristics and risk-stratified treatment strategy in lung adenocarcinoma. Cancer Lett 638:218158. https:\/\/doi.org\/10.1016\/j.canlet.2025.218158","journal-title":"Cancer Lett"},{"key":"1969_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/19396368.2024.2384386","volume":"70","author":"D Sherpa","year":"2024","unstructured":"Sherpa D, Bhowmick C, Pavan T, Rajwade DA, Halder S, Mitra I, Sharma S, Chakraborty P, Dasgupta S et al (2024) Classification of idiopathic recurrent spontaneous miscarriage using FTIR and Raman spectroscopic fusion technology. Syst Biol Reprod Med 70:228\u2013239. https:\/\/doi.org\/10.1080\/19396368.2024.2384386","journal-title":"Syst Biol Reprod Med"},{"key":"1969_CR55","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"1969_CR56","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A (2026) Cancer statistics, 2026. CA Cancer J Clin 76:e70043. https:\/\/doi.org\/10.3322\/caac.70043","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1969_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2017","unstructured":"Sigismund S, Avanzato D, Lanzetti L (2017) Emerging functions of the EGFR in cancer. Mol Oncol 12(1):3\u201320. https:\/\/doi.org\/10.1002\/1878-0261.12155","journal-title":"Mol Oncol"},{"key":"1969_CR58","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1158\/0008-5472.CAN-17-1605","volume":"77","author":"S Sivakumar","year":"2017","unstructured":"Sivakumar S, Lucas FAS, McDowell TL, Lang W, Xu L, Fujimoto J, Zhang J, Futreal PA, Fukuoka J et al (2017) Genomic landscape of atypical adenomatous hyperplasia reveals divergent modes to lung adenocarcinoma. Cancer Res 77:6119\u20136130. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1605","journal-title":"Cancer Res"},{"key":"1969_CR59","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2013.02.018","volume":"50","author":"EL Snyder","year":"2013","unstructured":"Snyder EL, Watanabe H, Magendantz M, Hoersch S, Chen TA, Wang DG, Crowley D, Whittaker CA, Meyerson M et al (2013) Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma. Mol Cell 50:185\u2013199. https:\/\/doi.org\/10.1016\/j.molcel.2013.02.018","journal-title":"Mol Cell"},{"key":"1969_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P et al (2019) Comprehensive Integration of Single-Cell Data. Cell 177:1888\u2013902. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031","journal-title":"Cell"},{"key":"1969_CR61","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1969_CR62","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer J Clin 71:209\u2013249","journal-title":"CA: A Cancer J Clin"},{"issue":"18","key":"1969_CR63","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.3390\/ijms22189953","volume":"22","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, Siemann DW (2021) Therapeutic Targeting of the Gas6\/Axl Signaling Pathway in Cancer. Int J Mol Sci 22(18):9953. https:\/\/doi.org\/10.3390\/ijms22189953","journal-title":"Int J Mol Sci"},{"key":"1969_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2019.02.014","volume":"199","author":"P Thandapani","year":"2019","unstructured":"Thandapani P (2019) Super-enhancers in cancer. Pharmacol Ther 199:129\u2013138. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.02.014","journal-title":"Pharmacol Ther"},{"key":"1969_CR65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16:385\u2013395","journal-title":"Stat Med"},{"key":"1969_CR66","doi-asserted-by":"publisher","first-page":"D280","DOI":"10.1093\/nar\/gkac968","volume":"51","author":"Y Wang","year":"2023","unstructured":"Wang Y, Song C, Zhao J, Zhang Y, Zhao X, Feng C, Zhang G, Zhu J, Wang F et al (2023) SEdb 2.0: a comprehensive super-enhancer database of human and mouse. Nucleic Acids Res 51:D280\u2013D290. https:\/\/doi.org\/10.1093\/nar\/gkac968","journal-title":"Nucleic Acids Res"},{"key":"1969_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111684","volume":"129","author":"X Wang","year":"2024","unstructured":"Wang X, Meng X, Cai G, Jin P, Bai M, Fu Y, Wang Z, Guo J, Han X (2024) Survival outcomes of targeted and immune consolidation therapies in locally advanced unresectable lung adenocarcinoma. Int Immunopharmacol 129:111684. https:\/\/doi.org\/10.1016\/j.intimp.2024.111684","journal-title":"Int Immunopharmacol"},{"key":"1969_CR68","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12885-022-09296-8","volume":"22","author":"S Wen","year":"2022","unstructured":"Wen S, Peng W, Chen Y, Du X, Xia J, Shen B, Zhou G (2022) Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO. BMC Cancer 22:193. https:\/\/doi.org\/10.1186\/s12885-022-09296-8","journal-title":"BMC Cancer"},{"key":"1969_CR69","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153:307\u2013319. https:\/\/doi.org\/10.1016\/j.cell.2013.03.035","journal-title":"Cell"},{"key":"1969_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature09881","volume":"473","author":"MM Winslow","year":"2011","unstructured":"Winslow MM, Dayton TL, Verhaak RGW, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA et al (2011) Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 473:101\u2013104. https:\/\/doi.org\/10.1038\/nature09881","journal-title":"Nature"},{"key":"1969_CR71","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41388-024-03261-4","volume":"44","author":"JA Woytash","year":"2024","unstructured":"Woytash JA, Kumar R, Chaudhary AK, Donnelly C, Wojtulski A, Bethu M, Wang J, Spernyak J, Bross P et al (2024) Mitochondrial unfolded protein response-dependent \u03b2-catenin signaling promotes neuroendocrine prostate cancer. Oncogene 44:820\u2013834. https:\/\/doi.org\/10.1038\/s41388-024-03261-4","journal-title":"Oncogene"},{"key":"1969_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W et al (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (n y) 2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"Innovation (n y)"},{"issue":"1","key":"1969_CR73","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"J-Y Xu","year":"2020","unstructured":"Xu J-Y, Zhang C, Wang X, Zhai L, Ma Y, Mao Y, Qian K, Sun C, Liu Z et al (2020) Integrative Proteomic Characterization of Human Lung Adenocarcinoma. Cell 182(1):245\u201361. https:\/\/doi.org\/10.1016\/j.cell.2020.05.043","journal-title":"Cell"},{"key":"1969_CR74","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2024","unstructured":"Yan Y, Sun D, Hu J, Chen Y, Sun L, Yu H, Xiong Y, Huang Z, Xia H et al (2024) Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Nat Genet 57:126\u2013139. https:\/\/doi.org\/10.1038\/s41588-024-01998-y","journal-title":"Nat Genet"},{"key":"1969_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.663509","volume":"8","author":"C Yifan","year":"2021","unstructured":"Yifan C, Jianfeng S, Jun P (2021) Development and validation of a random forest diagnostic model of acute myocardial infarction based on ferroptosis-related genes in circulating endothelial cells. Front Cardiovasc Med 8:663509. https:\/\/doi.org\/10.3389\/fcvm.2021.663509","journal-title":"Front Cardiovasc Med"},{"key":"1969_CR76","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612","journal-title":"Nat Commun"},{"key":"1969_CR77","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.7150\/thno.45349","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wei S, Sun W-P, Teng K, Dai M-M, Wang F-W, Chen J-W, Ling H, Ma X-D et al (2020) Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of hepatocellular carcinoma. Theranostics 10:9066\u20139082. https:\/\/doi.org\/10.7150\/thno.45349","journal-title":"Theranostics"},{"key":"1969_CR78","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.lungcan.2020.09.014","volume":"149","author":"J Zhao","year":"2020","unstructured":"Zhao J, Guo C, Ma Z, Liu H, Yang C, Li S (2020) Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: a comprehensive analysis based on TCGA and GEO databases. Lung Cancer 149:90\u201396. https:\/\/doi.org\/10.1016\/j.lungcan.2020.09.014","journal-title":"Lung Cancer"},{"issue":"1","key":"1969_CR79","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/cancers18010160","volume":"18","author":"S Zhao","year":"2026","unstructured":"Zhao S, Zhang H, Mu Q, Jiang Y, Zhao X, Wang K, Shi Y, Li X, Sun D (2026) Integrative Single-Cell and Machine Learning Analysis Identifies a Nucleotide Metabolism-Related Signature Predicting Prognosis and Immunotherapy Response in LUAD. Cancers 18(1):160. https:\/\/doi.org\/10.3390\/cancers18010160","journal-title":"Cancers"},{"key":"1969_CR80","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","volume":"54","author":"J Zhu","year":"2022","unstructured":"Zhu J, Fan Y, Xiong Y, Wang W, Chen J, Xia Y, Lei J, Gong L, Sun S et al (2022) Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Exp Mol Med 54:2060\u20132076. https:\/\/doi.org\/10.1038\/s12276-022-00896-9","journal-title":"Exp Mol Med"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01969-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01969-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:03:32Z","timestamp":1784041412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01969-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1969"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01969-y","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}